Effect of restrictive versus liberal red cell transfusion strategies on haemostasis: systematic review and meta-analysis

被引:7
|
作者
Desborough, Michael J. R. [1 ,2 ]
Colman, Katherine S. [3 ]
Prick, Babette W. [4 ]
Duvekot, Johannes J. [4 ]
Sweeney, Connor [5 ]
Odutayo, Ayodele [6 ]
Jairath, Vipul [7 ,8 ,9 ,10 ]
Doree, Carolyn [11 ]
Trivella, Marialena [6 ]
Hopewell, Sally [12 ]
Estcourt, Lise J. [1 ,2 ]
Stanworth, Simon J. [1 ,2 ]
机构
[1] NHS Blood & Transplant, Oxford, England
[2] Univ Oxford, Oxford Clin Res Transfus Med, Oxford, England
[3] Monash Univ, Med Sch, Melbourne, Vic, Australia
[4] Erasmus MC, Dept Obstet & Gynaecol, Rotterdam, Netherlands
[5] Oxford Univ Hosp NHS Fdn Trust, Dept Haematol, Oxford, England
[6] Univ Oxford, Ctr Stat Med, Oxford, England
[7] Western Univ, Dept Med, London, ON, Canada
[8] Western Univ, Dept Epidemiol, London, ON, Canada
[9] Western Univ, Dept Biostat, London, ON, Canada
[10] Univ Oxford, Nuffield Dept Med, Oxford, England
[11] NHS Blood & Transplant, Systemat Review Initiat, Oxford, England
[12] Univ Oxford, Nuffield Dept Orthopaed, Oxford Clin Trials Res Unit, Oxford, England
关键词
Haemorrhage; myocardial infarction; transfusion; stroke; venous thromboembolism; RANDOMIZED CONTROLLED-TRIAL; BLOOD-CELLS; BLEEDING-TIME; THRESHOLD; CORONARY; RISK; REQUIREMENTS; FEASIBILITY; AGGREGATION; MULTICENTER;
D O I
10.1160/TH17-01-0015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Red cells play a key role in normal haemostasis in vitro but their importance clinically is less clear. The objective of this meta-analysis was to assess if correction of anaemia by transfusing red cells at a high haemoglobin threshold (liberal transfusion) is superior to transfusion at a lower haemoglobin threshold (restrictive transfusion) for reducing the risk of bleeding or thrombotic events. We searched for randomised controlled trials in any clinical setting that compared two red cell transfusion thresholds and investigated the risk of bleeding. We searched for studies published up to October 19, 2016 in The Cochrane Central Register of Controlled Trials, MEDLINE, PubMed, Embase, and the Transfusion Evidence Library and ISI Web of Science. Relative risks (RR) or Peto Odds Ratios (pOR) were pooled using a random-effect model. Nineteen randomised trials with 9852 participants were eligible for inclusion in this review. Overall there was no difference in the risk of any bleeding between transfusion strategies (RR 0.91, 95 % confidence interval [CI] 0.74 to 1.12). The risk of severe or life-threatening bleeding was lower with a restrictive strategy (RR 0.75, 95 % CI 0.57 to 0.99). There was no difference in the risk of thrombotic events (RR 0.83, 95 % CI 0.61 to 1.13). The risk of any bleeding was not reduced with liberal transfusion and there was no overall difference in the risk of thrombotic events. Data from the included trials do not support aiming for a high haemoglobin threshold to improve haemostasis.
引用
收藏
页码:889 / 898
页数:10
相关论文
共 50 条
  • [21] Restrictive versus liberal transfusion strategy for red blood cell transfusion in critically ill patients and in patients with acute coronary syndrome: a systematic review, meta-analysis and trial sequential analysis
    Ripolles Melchor, Javier
    Casans Frances, Ruben
    Espinosa, Angel
    Martinez Hurtado, Eugenio
    Navarro Perez, Rosalia
    Abad Gurumeta, Alfredo
    Basora, Misericordia
    Calvo Vecino, Jose M.
    MINERVA ANESTESIOLOGICA, 2016, 82 (05) : 582 - 598
  • [22] Liberal versus restrictive transfusion strategies in acute myocardial infarction: a systematic review and comparative frequentist and Bayesian meta-analysis of randomized controlled trials
    Braik, Rayan
    Jebali, Safa
    Blot, Pierre-Louis
    Egbeola, Julia
    James, Arthur
    Constantin, Jean-Michel
    ANNALS OF INTENSIVE CARE, 2024, 14 (01):
  • [23] Liberal Transfusion versus Restrictive Transfusion and Outcomes in Critically Ill Adults: A Meta-Analysis
    Zhang, Wei
    Zheng, Yan
    Yu, Kun
    Gu, Juan
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2021, 48 (01) : 60 - 68
  • [24] Restrictive vs. Liberal Red Blood Cell Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: A Systematic Review and Meta-Analysis
    Zhang, Yeshen
    Xu, Zhengrong
    Huang, Yuming
    Ye, Qirao
    Xie, Nianjin
    Zeng, Lihuan
    Lian, Xingji
    Dai, Yining
    Chen, Jiyan
    He, Pengcheng
    Tan, Ning
    Liu, Yuanhui
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [25] Restrictive versus liberal transfusion strategies in patients with malignant neoplasm -a meta-analysis of randomized controlled trials
    Yang, Xin-xin
    Dai, Xiao-ce
    Liu, Chen-xin
    Lu, Jia-hong
    Lin, Sheng-yun
    TRANSFUSION AND APHERESIS SCIENCE, 2020, 59 (05)
  • [26] Restrictive Red Blood Cell Transfusion Strategies In Patients With Cardiovascular Disease: A Meta-Analysis
    Puch, I. Cortes
    Wiley, B. M.
    Klein, H. G.
    Welsh, J.
    Danner, R. L.
    Sun, J.
    Eichacker, P.
    Natanson, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [27] Surgery: Restrictive versus liberal red-cell transfusion
    Huynh K.
    Nature Reviews Cardiology, 2018, 15 (1) : 2 - 2
  • [28] Restrictive versus Liberal Transfusion Strategies in Acute Myocardial Infarction and Anemia: A Meta-Analysis and Trial Sequential Analysis
    Fabiano, Ronaldo C.
    Melo, Lara
    Nogueira, Alleh
    Gewehr, Douglas M.
    Generoso, Giuliano
    Cardoso, Rhanderson
    Bittencourt, Marcio S.
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2024, 121 (09)
  • [29] Efficacy and safety of restrictive versus liberal blood transfusion strategies in acute myocardial infarction and anemia: a systematic review and meta-analysis of randomized controlled trials
    Amin, Ahmed Mazen
    Ali, Karim
    Elbenawi, Hossam
    Saber, Alhassan
    Abuelazm, Mohamed
    Abdelazeem, Basel
    CORONARY ARTERY DISEASE, 2024, 35 (03) : 239 - 251
  • [30] How low should we go: A systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology
    Prescott, Lauren S.
    Taylor, Jolyn S.
    Lopez-Olivo, Maria A.
    Munsell, Mark F.
    VonVille, Helena M.
    Lairson, David R.
    Bodurka, Diane C.
    CANCER TREATMENT REVIEWS, 2016, 46 : 1 - 8